SYSTEMS AND METHODS FOR MULTIPLEX ANALYSIS OF PCR IN REAL TIME

• US 20080305481A1
• Filed: 12/13/2007
• Published: 12/11/2008
• Est. Priority Date: 12/13/2006
• Status: Active Grant

• Current Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Original Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Inventors: Collins, Charles J., Whitman, Douglas F.
• Granted Patent: US 7,955,802 B2
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6804 Nucleic acid analysis using immunogens immunoassay G01N33/53
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 2531/113 PCR
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2561/113 Real time assay
• CPC Class Codes: C12Q 2563/143 Magnetism, e.g. magnetic label

Abstract

The present invention provides methods and systems for real-time measurements of PCR with multiplexing capability. Certain embodiments relate to methods and systems that use fluorescently encoded superparamagnetic microspheres for the immobilization of amplification products during the PCR process, and an imaging chamber of a measurement device that is also capable of controllable thermal cycling for assisting the PCR process.

Claims

1. A method of amplifying and detecting a plurality of nucleic acid targets in a sample comprising:

(a) combining in a chamber a sample comprising the plurality of nucleic acid targets, a plurality of primer pairs for priming amplification of the plurality of nucleic acid targets, a labeling agent, and a first plurality of probes complementary to the plurality of nucleic acid targets, wherein the probes are immobilized on a plurality of encoded magnetic beads such that the identity of each probe is known from the encoded magnetic bead on which it is immobilized;

(b) performing an amplification cycle to form labeled amplification products for each of the plurality of nucleic acid targets amplified with the plurality of primer pairs;

(c) hybridizing the labeled amplification products to the probes immobilized on the encoded magnetic beads;

(d) applying a magnetic field to a surface of the chamber to draw the encoded magnetic beads and the labeled amplification products hybridized to the probes immobilized on the encoded magnetic beads to the surface of the chamber;

(e) detecting a signal from the encoded magnetic beads and a signal from the labeled amplification products;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the plurality of nucleic acid targets in the sample are amplified and detected.

2. The method of claim 1, further comprising correlating the signal from the labeled amplification product with the concentration of the nucleic acid target in the sample.

3. The method of claim 1, wherein the plurality of primer pairs is further defined as between 8 to 500 distinct primer pairs.

4. The method of claim 1, wherein the labeling agent is attached to one primer of each of the primer pairs.

5. The method of claim 1, wherein the chamber is a quartz chamber.

6. The method of claim 1, wherein the labeling agent is a fluorescent dye.

7. The method of claim 1, wherein the labeling agent is a fluorescence resonance energy transfer pair.

8. The method of claim 1, further comprising combining in the chamber a second plurality of probes complementary to the plurality of nucleic acid targets, wherein the second plurality of probes are not immobilized on the plurality of encoded magnetic beads and further wherein the second plurality of probes are complementary to different regions on the plurality of nucleic acid targets than the first plurality of probes.

9. The method of claim 8, wherein one member of a fluorescence resonance energy transfer pair is attached to the first plurality of probes immobilized on the encoded magnetic beads and the other member of the fluorescence resonance energy transfer pair is attached to the second plurality of probes that are not immobilized on the encoded magnetic beads.

10. The method of claim 1, wherein the labeling agent is a fluorophore and quencher pair.

11. The method of claim 1, wherein the labeling agent is a DNA intercalating agent.

12. The method of claim 1, wherein the encoded magnetic beads are encoded with fluorescent dyes.

13. The method of claim 12, wherein the encoded magnetic beads are encoded with different fluorescent intensities.

14. The method of claim 12, wherein the encoded magnetic beads are encoded with different fluorescent emission wavelengths.

15. The method of claim 1, wherein the encoded magnetic beads are superparamagnetic.

16. The method of claim 1, wherein applying the magnetic field comprises placing a permanent magnet adjacent to the surface of the chamber.

17. The method of claim 1, wherein applying the magnetic field comprises turning on an electromagnet adjacent to the surface of the chamber.

18. The method of claim 1, wherein the magnetic field is applied during a primer annealing phase of the amplification cycle.

19. The method of claim 1, wherein the magnetic field is applied during a primer extension phase of the amplification cycle.

20. The method of claim 1, wherein the magnetic field is applied following the amplification cycle.

21. The method of claim 1, wherein detecting the encoded magnetic beads and the labeled amplification products comprises imaging fluorescent wavelengths emitted from the encoded magnetic beads and the labeled amplification products.

22. The method of claim 1, wherein removing the magnetic field comprises removing a permanent magnet from a position adjacent to the surface of the chamber.

23. The method of claim 1, wherein removing the magnetic field comprises turning off an electromagnet adjacent to the surface of the chamber.

24. The method of claim 1, wherein steps (b) through (f) are repeated between 10 to 40 times.

25. The method of claim 1, wherein the plurality of probes comprise a blocked 3′

hydroxyl group.

26. The method of claim 25, wherein the 3′

hydroxyl group is blocked with a phosphate group.

27. The method of claim 25, wherein the 3′

hydroxyl group is blocked with a 3′

inverted dT.

28. A method of amplifying and detecting a plurality of nucleic acid targets in a sample comprising:

(a) combining in a chamber a sample comprising the plurality of nucleic acid targets, a plurality of primer pairs for priming amplification of the plurality of nucleic acid targets, and a plurality of molecular beacons complementary to the plurality of nucleic acid targets, wherein the molecular beacons are immobilized on a plurality of encoded magnetic beads such that the identity of each molecular beacon is known from the encoded magnetic bead on which it is immobilized;

(b) performing an amplification cycle to form amplification products for each of the plurality of nucleic acid targets amplified with the plurality of primer pairs;

(c) hybridizing the amplification products to the molecular beacons immobilized on the encoded magnetic beads;

(d) applying a magnetic field to a surface of the chamber to draw the encoded magnetic beads and the amplification products hybridized to the molecular beacons immobilized on the encoded magnetic beads to the surface of the chamber;

(e) detecting a signal from the encoded magnetic beads and a signal from the molecular beacons;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the plurality of nucleic acid targets in the sample are amplified and detected.

29. A method of amplifying and detecting a nucleic acid target in a sample comprising:

(a) combining in a chamber a sample comprising the nucleic acid target, a primer pair for priming amplification of the nucleic acid target, and a probe set complementary to the nucleic acid target, wherein the probe set comprises a first probe immobilized on a magnetic bead, and a second probe comprising a label;

(b) performing an amplification cycle to form amplification products for the nucleic acid target amplified with the primer pair;

(c) hybridizing the amplification products to the probe set;

(d) applying a magnetic field to a surface of the chamber to draw the magnetic bead and the amplification products hybridized to the probe immobilized on the encoded magnetic bead to the surface of the chamber;

(e) detecting a signal from the second probe hybridized to the amplification products;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the nucleic acid target in the sample is amplified and detected.

30. The method of claim 29, wherein the magnetic bead is an encoded magnetic bead.

31. The method of claim 29, further defined as a method of amplifying and detecting a plurality of nucleic acid targets comprising:

(a) combining in the chamber a sample comprising a plurality of nucleic acid targets, a plurality of primer pairs for priming amplification of the plurality of nucleic acid targets, and a plurality of probe sets complementary to the plurality of nucleic acid targets, wherein each probe set comprises a first probe immobilized on an encoded magnetic bead such that the identity of the first probe is known from the encoded magnetic bead on which it is immobilized, and a second probe comprising a label;

(b) performing an amplification cycle to form amplification products for each of the plurality of nucleic acid targets amplified with the plurality of primer pairs;

(c) hybridizing the amplification products to the probe sets;

(d) applying a magnetic field to a surface of the chamber to draw the encoded magnetic beads and the amplification products hybridized to the probes immobilized on the encoded magnetic beads to the surface of the chamber;

(e) detecting a signal from the encoded magnetic beads and a signal from the second probe hybridized to the amplification products;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the plurality of nucleic acid targets in the sample are amplified and detected.

32. A method of amplifying and detecting a nucleic acid target in a sample comprising:

(a) combining in a chamber a sample comprising the nucleic acid target, a primer pair for priming amplification of the nucleic acid target, a dNTP coupled to a quencher molecule, and a fluorescently labeled probe complementary to the nucleic acid target, wherein the probe is immobilized on a magnetic beads;

(b) performing an amplification cycle to form amplification products of the nucleic acid target, the amplification products comprising quencher molecules;

(c) hybridizing the amplification products to the probe immobilized on the magnetic bead;

(d) applying a magnetic field to a surface of the chamber to draw the magnetic bead and the amplification products hybridized to the probe immobilized on the encoded magnetic bead to the surface of the chamber;

(e) detecting a signal from the labeled probe, wherein a decrease in the signal from the labeled probe indicates hybridization of the labeled probe to the amplification products comprising quencher molecules;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the nucleic acid target in the sample is amplified and detected.

33. The method of claim 32, wherein the magnetic bead is an encoded magnetic bead.

34. The method of claim 32, further defined as a method of amplifying and detecting a plurality of nucleic acid targets comprising:

(a) combining in the chamber a sample comprising the plurality of nucleic acid targets, a plurality of primer pairs for priming amplification of the plurality of nucleic acid targets, a dNTP coupled to a quencher molecule, and a plurality of fluorescently labeled probes complementary to the plurality of nucleic acid targets, wherein the probes are immobilized on a plurality of encoded magnetic beads such that the identity of each probe is known from the encoded magnetic bead on which it is immobilized;

(b) performing an amplification cycle to form amplification products comprising quencher molecules for each of the plurality of nucleic acid targets amplified with the plurality of primer pairs;

(c) hybridizing the amplification products to the probes immobilized on the encoded magnetic beads;

(d) applying a magnetic field to a surface of the chamber to draw the encoded magnetic beads and the amplification products hybridized to the probes immobilized on the encoded magnetic beads to the surface of the chamber;

(e) detecting a signal from the encoded magnetic beads and a signal from the labeled probes, wherein a decrease in the signal from the labeled probes indicates hybridization of the labeled probes to the amplification products comprising quencher molecules;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the plurality of nucleic acid targets in the sample are amplified and detected.

35. A method of amplifying and detecting a plurality of nucleic acid targets in a sample comprising:

(a) combining in a chamber a sample comprising the plurality of nucleic acid targets;

a plurality of primer pairs for priming amplification of the plurality of nucleic acid targets, wherein each primer pair comprises a first primer comprising a target specific sequence, a tag sequence 5′

of the target specific sequence, and a blocker between the target specific sequence and the tag sequence, and a second primer comprising a target specific sequence;

a labeling agent; and

a plurality of probes complementary to the tag sequences of the plurality of primer pairs, wherein the probes are immobilized on a plurality of encoded magnetic beads such that the identity of each probe is known from the encoded magnetic bead on which it is immobilized;

(b) performing an amplification cycle to form tagged and labeled amplification products for each of the plurality of nucleic acid targets amplified with the plurality of primer pairs;

(c) hybridizing the tagged and labeled amplification products to the probes immobilized on the encoded magnetic beads;

(d) applying a magnetic field to a surface of the chamber to draw the encoded magnetic beads and the tagged and labeled amplification products hybridized to the probes immobilized on the encoded magnetic beads to the surface of the chamber;

(e) detecting the encoded magnetic beads and the tagged and labeled amplification products;

(f) removing the magnetic field from the surface of the chamber prior to performing a further amplification cycle; and

(g) repeating steps (b) through (f) at least once;

wherein the plurality of nucleic acid targets in the sample are amplified and detected.

36. The method of claim 35, wherein the labeling agent is a reporter molecule attached to the second primer of the primer pair.

37. The method of claim 35, wherein the labeling agent is an intercalating dye.